LK
Lalit Kapoor• 2h ago
Emcure Pharma experienced a significant block trade worth approximately INR 98 crore on NSE, involving around 614,310 shares and priced at INR 1600.6 each.
Price History
Emcure Pharma experienced a significant block trade worth approximately INR 98 crore on NSE, involving around 614,310 shares and priced at INR 1600.6 each.
Emcure Pharma's subsidiary, Mantra Pharma, has purchased Cutimed Inc. for CAD 5.05M, bolstering their Canadian dermatology and cosmetics offerings by merging with the Canadian company.